---
title: "Wuxi XDC enters strategic collaboration with Earendil Labs"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277194774.md"
description: "Wuxi XDC enters strategic collaboration with Earendil Labs"
datetime: "2026-02-27T12:01:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277194774.md)
  - [en](https://longbridge.com/en/news/277194774.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277194774.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/277194774.md) | [繁體中文](https://longbridge.com/zh-HK/news/277194774.md)


# Wuxi XDC enters strategic collaboration with Earendil Labs



### Related Stocks

- [China Merchants CSI Biotechnology Theme ETF (159849.CN)](https://longbridge.com/en/quote/159849.CN.md)
- [ChinaAMC SSE Health Care ETF Initiating Fund (510660.CN)](https://longbridge.com/en/quote/510660.CN.md)
- [Yinhua CSI Innovative Drugs Industry ETF (159992.CN)](https://longbridge.com/en/quote/159992.CN.md)
- [ChinaAMC CSI Biotechnology Theme ETF (516500.CN)](https://longbridge.com/en/quote/516500.CN.md)
- [Founder Fubon CSI Medicine and Medical Device Innovation ETF (560600.CN)](https://longbridge.com/en/quote/560600.CN.md)
- [Ping An CSI Medicine and Medical Device Innovation ETF (516820.CN)](https://longbridge.com/en/quote/516820.CN.md)
- [ICBCCS SSE STAR Biology and Medicine ETF (588860.CN)](https://longbridge.com/en/quote/588860.CN.md)
- [ChinaAMC SSE STAR Biology and Medicine ETF (588130.CN)](https://longbridge.com/en/quote/588130.CN.md)
- [Guotai CSI Bio-medicine ETF (512290.CN)](https://longbridge.com/en/quote/512290.CN.md)
- [Minsheng Royal CSI Biotechnology Theme ETF (516930.CN)](https://longbridge.com/en/quote/516930.CN.md)
- [WUXI XDC (02268.HK)](https://longbridge.com/en/quote/02268.HK.md)
- [Tianhong CNI BIOMEDICINE ETF (159859.CN)](https://longbridge.com/en/quote/159859.CN.md)
- [E Fund CSI 300 Health Care ETF (512010.CN)](https://longbridge.com/en/quote/512010.CN.md)
- [E Fund CSI Biotechnology Theme ETF (159837.CN)](https://longbridge.com/en/quote/159837.CN.md)
- [Penghua SSE STAR Biology and Medicine ETF (588250.CN)](https://longbridge.com/en/quote/588250.CN.md)

## Related News & Research

- [Hangzhou Jiuyuan’s Semaglutide Biosimilar Jikeqin Advances Toward China Market Approval](https://longbridge.com/en/news/276936312.md)
- [China's Jiuyuan Genetic seeks approval for Wegovy biosimilar](https://longbridge.com/en/news/276994337.md)
- [Henlius Biotech Doses First Patient in Phase 2/3 Breast Cancer Drug Study; Shares Slip 3%](https://longbridge.com/en/news/277421361.md)
- [Antengene Signs Global License Deal With UCB for Autoimmune Drug Candidate](https://longbridge.com/en/news/277705757.md)
- [SinoMab Wins China IND Nod to Expand SM17 Into Inflammatory Bowel Disease](https://longbridge.com/en/news/276765156.md)